Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypereosinophilia in a horse with intestinal lymphosarcoma.

Literature DB >> 9360792

Hypereosinophilia in a horse with intestinal lymphosarcoma.

Abstract

Paraneoplastic eosinophilia is reported in dogs, cats, and humans. Hypereosinophilia (an eosinophil count greater than 1.5 x 10(9) L) is often associated with metastasis and a poor prognosis. This report describes a case of paraneoplastic hypereosinophilia in a pony. Neoplasia should be included in the differential diagnoses in a horse with eosinophilia.

Entities: Disease Species

Mesh：

Year: 1997 PMID： 9360792 PMCID： PMC1576821

Source DB: PubMed Journal: Can Vet J ISSN： 0008-5286 Impact factor: 1.008

14 in total

1. Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice.

Authors: A A Mahmoud; M K Stone; R W Kellermeyer
Journal: J Clin Invest Date: 1977-09 Impact factor: 14.808

2. Evidence for the neoplastic involvement of monocytic, eosinophilic and basophilic lineages in acute myelomonocytic leukemia with eosinophilia.

Authors: K Yanagisawa; T Fukuoka; S Fujita
Journal: Acta Haematol Date: 1990 Impact factor: 2.195

3. Severe eosinophilia associated with a malignant islet cell tumour.

Authors: J H Haldane; H Kapoor; J Morris
Journal: CMAJ Date: 1989-05-01 Impact factor: 8.262

4. Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cells.

Authors: D S Silberstein; D D Schoof; M L Rodrick; P C Tai; C J Spry; J R David; T J Eberlein
Journal: J Immunol Date: 1989-03-15 Impact factor: 5.422

5. Immunologic and hematologic responses in ponies with experimentally induced Strongylus vulgaris infection.

Authors: M Bailey; S C Martin; S Lloyd
Journal: Am J Vet Res Date: 1989-08 Impact factor: 1.156

6. Persisting hypereosinophilia and myocardial activity in the fibrotic stage of endomyocardial disease.

Authors: A Frustaci; A K Abdulla; G Possati; U Manzoli
Journal: Chest Date: 1989-09 Impact factor: 9.410

7. Acute nonlymphocytic leukemia with eosinophilic differentiation.

Authors: A G Gabbas; C Y Li
Journal: Am J Hematol Date: 1986-01 Impact factor: 10.047

8. Eosinophilic myeloproliferative disorder in a horse.

Authors: D D Morris; J C Bloom; K A Roby; K Woods; F Tablin
Journal: J Am Vet Med Assoc Date: 1984-11-01 Impact factor: 1.936

9. Differential regulation of the low affinity Fc receptor for IgE (Fc epsilon R2/CD23) and the IL-2 receptor (Tac/p55) on eosinophilic leukemia cell line (EoL-1 and EoL-3).

Authors: M Hosoda; S Makino; T Kawabe; Y Maeda; S Satoh; M Takami; M Mayumi; K Arai; H Saitoh; J Yodoi
Journal: J Immunol Date: 1989-07-01 Impact factor: 5.422

10. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors: Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal: J Exp Med Date: 1988-05-01 Impact factor: 14.307

2 in total

1. Eosinophilia in a cat with acute leukemia.

Authors: Cornelia Gilroy; María Forzán; Anne Drew; William Vernau
Journal: Can Vet J Date: 2011-09 Impact factor: 1.008

2. Spinal extradural T-cell lymphoma with paraneoplastic hypereosinophilia in a dog: clinicopathological features, treatment, and outcome.

Authors: Katie A McNaught; Joanna Morris; Kali Lazzerini; Caroline Millins; Roberto José-López
Journal: Clin Case Rep Date: 2018-04-06

2 in total